• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/90

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

90 Cards in this Set

  • Front
  • Back
Micro 38: Human Retroviruses
Micro 38: Human Retroviruses
associated with leukemia and lymphoma
HTLV-1
causes AIDS
HIV
HIV binds to
CD4 molecule found on TH cells and monocytes
latency of HIV
usually long ~10 years
pneumonia associated with end stage AIDS
Pneumocystis jiroveci
What makes AIDS unique amongst infectious diseases
1. uniformly fatal 2. most devistating effects not directly caused by the HIV agent
retrovivuses are ___________ viruses that contain _____________ enzyme
RNA viruses, contain reverse transcriptase
structure of RNA molecule
small sphrical virion surrounded by lipid envelope
retrovirus genome
2 identical RNA molecules
how does retrovirus RNA resemble eukaryotic RNA
has a cap at 5' end and poly A sequence at 3' end
gag gene
encodes core proteins
pol gene
encodes reverse transcriptase (RNA dependent DNA polymerase) and integrase which is required for integration of viral DNA into host genome
integrase
required for integration of viral DNA into host genome
env gene
encodes gp120 and gp41
pro gene
encodes a protease necessary for cleaving and activation Gag and Pol proteins to active forms
4 genes required for replicaton of retrovirus
gag, pol, env, pro
3 major routes of HIV transmission
sexual contact, IV drug use, vertical (mother to baby)
accounts for 1/3 HIV transmissions
heterosexual transmission
accounts for 1/6 HIV transmissions
IV drug use
why are hemophiliacs at higher risk for bloodbourne viruses
they get factor VIII from plasma pooled from thousands of donors; they are more likely to get hep B/C than HIV because of more rigorous screening for HIV antibodies
most common form of spread HIV in most countries outside US and europe
heterosexual transmission
transmission risk between infected and unifnected spouses
~0.3%
transmission rates are higher between spouces when
when infected partner has higher viral load,
these men are more suscptable to HIV invfection
uncircumcised
sex associated with ___________ more often results in HIV transmission
trauma
CCR5 and HIV
this gene is defective in 10% of europeans. If homozygous defective (~1% of the 10%) ; a strong but not absolute resistance to HIV infection is confered
heterozygous CCR5 mutants and aids
have slower progression
homozygous CCR5 mutants and AIDS
have high level of resistance to infection
can interrupt maternofetal transmission of HIV
antiretroviral drugs
transmission rate from mother to baby if HIV is untreated
~25-33% (less than 1% if treated)
needle stick HIV transmission risk
~0.3%
entry of HIV
poorly understood, may be within infected cells or even as free virus
spread of HIV to nonsexual contacts (both family and professional, social)
virtually nonexistant
major cell types infected by HIV
helper T lymphocytes and monocytes
faciltates early HIV binding to CD4 molecule
gp120
antibodies to this can prevent HIV infection
gp120
after CD4 binding to gp120 what happens
gp12 engages either CCR5 or CXCR4 for secondary binding
physiological purpose of CCR5 and CXCR4
binding site for chemokines
binding of gp120 to CCR5 or CXCR4 triggers what
conformational change in gp41
fusion of viral envelope to cell membrane is facilitated by
gp41 and target cell membrane
long terminal repeat
result of reverse transcriptase converting the ends of viral genomic RNA
joins ends of LTR to host DNA
integrase
provirus
integrated viral genetic material analagous to a cellular gene
how is the progeny virus synthesized
the integrated viral DNA is transcribed and is directed y signals from LTR section. The viral RNA molecules are produced and some are used for synthesis of viral protiens while others are used for genomes of progeny. The new virus gets its enevlope by passing through host membrane
latent phase
infected cells contain provirus but do not express viral RNA or proteins
transactivation
expression of HIV macromolecules is subject to regulation by viral gene products that operate as soluable elements in trans
regulates transativation
tat and rev
transactivating factors greatly
enhance expression of viral RNAs and proteins
Tat protein
accellerated transcription of viral RNA by host RNA ply
Rev protein
enhances transport of some viral RNAs from nucleus to cytoplasm
Nef protein
downregulates cell expression of MHC 1 molecules
Vif protein
facilitates destruction of ABOBEC 3G which is a cellular protein that is capable of blocking reverse transcription when packaged in the viral particle
Vpu
downregulates IFN induced cellular protein tetherin
tetherin
inhibits release of viral particles from cell surface
3 ways HIV persists in host despite antiviral immune response.
1. viral gene products are relatively invisable to immune response 2. viral may change antigenic spcificity 3. virus replicates in lymph follicles where virus directed immune cells cannot migrate freely
which HIV gene shows much variation ; which are stable
Env shows many variations, Gag and Pol are fairly stable
unique and protective (to the virus) features of HIV envelope glycoproteins
extensive polysaccride coating (less immunogenic) and hypervariable antigenic configurations
2 groups of retroviruses that cause human disease
HTLV group and Lentiviruses (HIV1-2)
HTLV1
causes T cell leukemias and lymphomas
HTLV 2
associated with cases of hairy cell leukemia
HIV1
causative agent of aids
HIV 2
related to HIV1 causes AIDS in West Africa
IL-2
stimulates growth of T lymphocytes in vitro
other infections (besides leukemia) associated with HTLV1
progressive spinal cord diseases
what determines if an acute HIV infection will persist
if immune response arrives before the first burst of the infection "dies out"
kills cells infected with HIV1
Tc cells ; antibody mediated cellular cytotoxicity, or viral replication itself
immune challenge of fighting HIV
the cells you are making to combat the virus are the same cells that are fueling it.
chronic phase is reached when
relative balance between immune response and viral replication
99% of HIV replication is said to occur where?
CD4+ lymphocytes in lymphoid organs
normal, symptomatic and advanced, late stage HIV T cell counts
~1000 ; ~500 ; ~200 ; ~50
why can HIV effect other cell types besides TH cells
CD4 can be found on cells monocyres NK cells and some macrophages making them sucesceptable to infection
AIDS conditions are characterized by
diarrhea, oral candidasis, weight loss, fever
category A HIV infection
asymptomatic, primary, or persistant generalized adenopathy
category B HIV infection
oropharyngeal candidasis, cervical dysplasica, constitutional symtpoms (diarrhea >1mo); oral hairy leukoplakia, recurrent herpes zoster, ITP, listerosis, PID …etc…
category C HIV infection
these are the bad ones; pretty much all disseminated viral/fungal/bacterial infections and more widespread candidasis and cancers such as kaopsi sarcoma, HL, NHL and burkitt will develop
most common presenting clinical manifestation of AIDS in untreated pt
P. jiroveci pneumonia (M tuberculosis if in zimbabwe)
associated with CNS manifestations of AIDS
T. gondii ; Cryptococcus neoformans
evidence of HIV infection is based on presense of
HIV antiviral antibodies
initial HIV test
ELISA (enzyme linked immunosorbent assay)
repeat (conformatory HIV test)
western blot (immunoblot)
first approved drug for HIV
AZT (zidovudine)
drug class of first antiretroviral drugs
reverse transcriptase inhibitors
NNRTIs
inhibit reverse transcriptase by bining to the enzyme at a site distant from the active site
dianosine, zalcitabine, stavudine, lamivudine, emtricitabine, tenofovir
reverse transcripase inhibitors ; cause premature termination of growing strands of viral DNA
nevirapine, efavirenz, delavirdine
NNRTIs
ralegravir
viral integrase inhibitor
ritonavir, indinvir, sauinavir, amprenavir, nelfinavir, arunavir, lopinavir
viral protease inhibitors
CCR5 inhibitors
can prevent entry of HIV particle, require susceptable testing
HIV therapy should include
3-4 drugs of varying mechanism for greatest outcome